GROUP 3

BSMLS1D

MALARIA
A H E A L T H R E P O R T
THE
CONTENTS

LIST OF TOPICS

History of Malaria
Morphology of Malaria
Pathology of Malaria
Treatment for Malaria
M A L A R I A
GROUP 3 BSMLS1D

HISTORY
The start of Malaria.

PALAOGENE 4TH 5TH MIDDLE EUROPEAN

PERIOD CENTURY CENTURY AGES RENAISSANCE
M A L A R I A
MOR

GROUP 3 BSMLS1D
PHO
LO
GY

Knowlesi

Gametocyte
M A L A R I A
GROUP 3 BSMLS1D

TERMS

S P O ROZO I T E
R I N G T RO P H OZO I T E
SCHI ZONT
OOKINETE
SCHI ZOGONY
OOCYST
MEROGONY
M E ROZO I T E
GROUP 3 BSMLS1D
PATHOLOGY
GROUP 3 BSMLS1D

OTHER MEANS OF TRANSMISSION

Mother to fetus
Blood transfusions
Shared needles

WHO ARE AT RISK?

Pregnant women
Infants
Children under age of 5
Patients with HIV/AIDS
Non-immune migrants
Travellers
GROUP 3 BSMLS1D

SIGNS AND SYMPTOMS OF MALARIA

Fever
Headache
Muscle pain
Fatigue
Nausea
Vomiting

OTHERS

Sweating
Abdominal or chest pain
Cough
Anemia
Respiratory distress
Multi-organ failure
Cerebral malaria
GROUP 3 BSMLS1D

MALARIA ATTACK
what is it?

Shivering and High fever Sweating Return to

chills body
temperature
M A L A R I A
GROUP 3 BSMLS1D

DIAGNOSIS

L A B O R ATO R Y RAPID P O LY M E R A S E
I N V E S T I G AT I O N DIAGNOSTIC CHAIN
Thick smear, Thin smear &
TESTS REACTION
Parasite density
GROUP 3 BSMLS1D

TREATMENT
Guided by three main factors:

THE INFECTING
PLASMODIUM SPECIES

T H E C L I N I C A L S TAT U S O F
T H E PAT I E N T
THE DRUG SUSCEPTIBILITY OF
T H E I N F E C T I N G PA R A S I T E S A S
DETERMINED BY THE
GEOGRAPHIC AREA WHERE THE
I N F E C T I O N WA S A C Q U I R E D A N D
THE PREVIOUS USE OF
ANTIMALARIAL MEDICINES
GROUP 3 BSMLS1D

TREATMENT
Other treatments:

S U P R E S S I V E T R E AT M E N T/
CHEMOPROPHYLAXIS

T H E R A P E U T I C T R E AT M E N T

G A M E TO C I D A L T R E AT M E N T

R A D I C A L T R E AT M E N T
SatoriHaus | 2020

MOST COMMON
ANTIMALARIAL DRUGS

Artemisinin-based combination
therapies (ACTs)

Chloroquine phosphate
GROUP 3 BSMLS1D

PREVENTION

C OV ER YOUR A P P LY I N S E C T SLEEP UNDER

SKIN R E P E L L A N T TO THE NET
SKIN AND
C L OT H I N G
GROUP 3 BSMLS1D

REMEMBER!
THERE'S STILL NO VACCINES
FOR MALARIA
 GROUP 3
BSMLS1D

MALARIA
A H E A L T H R E P O R T
 RESOURCES

Centers for Disease Control and Prevention (2018). Malaria. Retrieved on June 24, 2019 from https://medical-dictionary.thefreedictionary.com/schizogony

Center for Disease Control and Prevention (n.d.). Malaria. Retrieved on June 24, 2019 from https://www.cdc.gov/dpdx/malaria/index.html

Keas, Brian (n.d.). Microscopy - Plasmodium Species. Retrieved on June 24, 2019 from https://msu.edu/course/zol/316/psppscope.htm

Silamut, Kamolrat (2013). Malaria parasites and morphology. Retrieved on June 21, 2019 from http://www.tropmedres.ac/_asset/file/malaria-parasites-and-morphology.pdf

The Free Dictionary (n.d.). Schizogony. Retrieved on June 24, 2019 from https://medical-dictionary.thefreedictionary.com/schizogony

Wiser, Mark (2011). Plasmodium Species Infecting Human. Retrieved on June 21, 2019 from https://www.tulane.edu/~wiser/protozoology/notes/pl_sp.html

World Health Organization (2019). Malaria. Retrieved on June 24, 2019 from https://www.who.int/news-room/fact-sheets/detail/malaria

https://www.cdc.gov/malaria/resources/pdf/clinicalguidance.pdf

https://www.mayoclinic.org/diseases-conditions/malaria/diagnosis-treatment/drc-20351190

https://www.mayoclinic.org/diseases-conditions/malaria/symptoms-causes/syc-20351184

https://en.wikipedia.org/wiki/History_of_malaria

https://www.ncbi.nlm.nih.gov/books/NBK215638/